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MicroRNAs (miRNAs) are emerging as novel regulators in gene expression. Due to the large population of 
miRNAs and their important function inside cells, miRNA network is essential for normal physiology but still 
remains unclear. Recent results also showed miRNAs are closely related with the occurrence and development of 
various human diseases. Thus, revealing miRNA network is urgently needed for not only biological studies but 
also medical treatment. Small molecules that can regulate miRNA pathway hold great potential in probing 
miRNA network. With developed cellular reporter system, we have found two small molecules from 
photoreaction products that can universally activate miRNA and specifically inhibit myomiRs. With the latter 
small molecule, a novel miRNA regulatory pathway, miR-221/222-myoD-myomiRs, was successfully unveiled. 
To cite this article: Jinbo Li, et al. Probing microRNA network with small molecules. RNA Dis 2014; 1: e450. doi: 
10.14800/rd.450. 
MicroRNAs (miRNAs) are tiny non-coding RNAs, which 
consist of ~22 nucleotides and play pivotal roles in regulation 
of gene expression 
[1]
. Generally, miRNAs interact with
target mRNAs through binding to their 3’ untranslated 
regions (UTR) in a manner of sequence complementarity, 
resulting in degradation or suppressed translation of target 
mRNAs. Previous researches have pointed out that over 30% 
of the human genome are under the regulation of miRNAs 
[2]
.
Together with the evidence that there are many miRNAs in 
human cells and one miRNA could target multiple mRNAs 
[3, 4]
, the network formed among miRNAs, their
transcriptional factors, target mRNAs, and other unknown 
biomolecules is thus extremely complicated but also 
fundamental in cells. As a result, abnormal miRNAs have 
found to be highly related with many human diseases 
including cancers 
[5, 6]
. It is therefore urgent and important to
explore miRNA network, which is also challenging due to 
lack of appropriate tools. 
Chemical genetic studies using small molecules with 
specific activity in biological systems have successfully 
dissected a considerable number of unknown signaling 
transduction pathways inside cells 
[7-9]
, indicating miRNA
network may also be unveiled by small molecules targeting 
the miRNA pathway. Recently, several small molecules that 
can adjust miRNA transcription, maturation or function have 
been reported by us and others 
[10-16]
, including specific or
universal modifiers of miRNAs. Note worthily, cellular iron 
homeostasis has been successfully connected with the 
miRNA pathway through a small-molecular activator of 
miRNA 
[17]
. Therefore, small molecules that can regulate
miRNA pathway hold great promise in probing unknown 
miRNA network. 
Our group aims to identify small molecules with 
regulatory activity toward miRNA pathway from a special 
compound library based on organic reactions and then 
employ these small molecules as tools to dig the miRNA 
network. To find out such small molecules, cellular reporter 
systems that can report changes in miRNA pathway were 
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developed by us at first. In specificity, luciferase reporter 
genes that contain complementary sequences of miRNAs at 
their 3’ UTR were transfected into cell lines with high 
expression levels of these miRNAs, resulting in the cellular 
reporter systems (Figure 1). Activity of candidate small 
molecules can then be read out by measuring luciferase 
signals. 
With the cellular reporter systems, we first identified a 
small molecule (1, Figure 1) as a universal activator of 
miRNAs, which were screened from photoreaction products 
[11]
. Small molecule 1 was found to promote maturation of 
miRNAs and stimulate protein expression levels of 
trans-activation-responsive region RNA-binding protein 
(TRBP) that is critical in miRNA processing. In the 
meanwhile, another small molecule (2, Figure 1) also from 
photoreaction products came out as an inhibitor of 
muscle-specific miR-1 
[14]
. Small molecule 2 inhibited miR-1 
without effects on other cancer-related miRNAs, indicating it 
may have specific activity toward myogenic miRNAs 
(myomiRs). 
  MyomiRs including miR-1, miR-133a, and miR-206 are 
overexpressed in muscle and cardiac cells, and are involved 
in both development and disease of heart or muscle 
[18, 19]
. 
Recent investigations also showed miR-133a is related with 
brown fat differentiation 
[20]
, indicating miR-133a may be 
involved in metabolic diseases. The discovery of unknown 
myomiR network shall benefit related studies and treatment. 
And we then checked the effect of small molecule 2 toward 
miR-133a and miR-206, showing both these two myomiRs 
could be inhibited by small molecule 2 
[15]
. These results 
confirmed the specific inhibitory activity of small molecule 2 
toward myomiRs. The expression levels of primary and 
mature myomiRs obtained from quantitative RT-PCR 
analysis showed both of them were decreased after treatment. 
At the same time, we observed that treatment with small 
molecule 2 led to inhibited differentiation of muscle cells, 
which was validated by quantitative RT-PCR analysis of 
differentiation-related genes. These results indicated factors 
in the transcriptional pathway that control myomiR 
expression and cell differentiation may be regulated by small 
molecule 2. Previous studies have demonstrated myoD is the 
major transcriptional factor of myomiR and also an important 
regulatory factor of muscle cell differentiation 
[21, 22]
. We thus 
then checked expression levels of myoD, leading to the 
discovery that protein expression was decreased by small 
molecule 2 while mRNA expression remained consistent. 
The unique expression patterns of myoD mRNA and protein 
inspired us that there may exist other miRNAs in the 
upstream pathway of myoD. After performing bioinformatic 
calculation, miR-221/222 that were already known to be 
related with the differentiation of skeletal muscle appeared 
[23, 24]
. MiR-221/222 could target the position 383-389 of 
myoD 3’ UTR and the free energies of miR-221/222-myoD 
hybrid were comparable to that of authentic miRNA-target 
pairs. Then, miR-221/222 expressions in muscle cells were 
investigated after treatment with small molecule 2, revealing 
their expression levels were up-regulated. To confirm the 
direct regulation of miR-221/222 on myoD, miR-221/222 
mimics or inhibitors were transfected into muscle cells, 
leading to repressed or enhanced protein expression of myoD 
respectively. And myoD 3’ UTR was inserted into the 3’ 
UTR of luciferase gene, luciferase signals were also found to 
be regulated by miR-221/222, demonstrating direct 
regulation of miR-221/222 on myoD. Importantly, mutation 
at position 383-389 of myoD 3’ UTR caused no interaction 
between miR-221/222 and luciferase gene, validating the 
result of bioinformatic calculation. The indirect regulation of 
miR-221/222 on myomiRs was also confirmed by measuring 
myomiR expression levels after overexpression or 
knockdown of miR-221/222. In summary, small molecule 
2successfully revealed a novel miRNA regulatory pathway in 
muscle cells, which is the miR-221/222-myoD-myomiRs 
pathway (Figure 2). 
Figure 1. Cellular reporter systems for identification of small molecules that can regulate 
miRNA pathway and identified small molecular modifiers of miRNAs. 
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Beside these two small molecules, we have also 
discovered some other small molecules with unique 
regulatory activity toward miRNA pathway and are now 
trying to explore relative miRNA network. In addition, 
functionalization of active small molecules with 
bioorthogonal group has recently shown as an efficient way 
for target identification and exploring unknown signaling 
pathways 
[25-27]
. And we are now trying to modify small 
molecule 1 and 2 with bioorthogonal groups to identify their 
direct targets. The discovery of their direct targets is 
expected to reveal more unknown factors in miRNA 
processing or myomiR network. With the identification of 
more active small molecules that can regulate miRNA 
pathway and further chemical modification, miRNA network 
is believed to get clear in the future. 
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